NCT04912063 · Interventional trial
Study to Evaluate Adverse Events and Movement of Lemzoparlimab in Body When Used Intravenously (IV) With Azacitidine Subcutaneously or IV and Venetoclax Orally in Participants With Acute Myeloid Leukemia and With Azacitidine With or Without Venetoclax in Participants With Myelodysplastic Syndrome
Overall registry status Terminated
Phase 1
Conditions Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS)
Delaware Valley sites
- University of Pennsylvania /ID# 227024 · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory